Supplier News

CombiLac is a lactose-based, co-processed excipient, designed to ease oral solid dosage form development and manufacture in direct compression.

The new Kaye Validator AVS combines accurate sensor measurements with all GMP requirements for calibration and traceability.

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility.

BASF announces that it will sell its custom synthesis business and parts of its API business to focus its expertise on pharmaceutical excipients.

Capsugel extends inhaled biotherapeutics delivery capability to Phase 2 clinical trials.

FDA cites Yunnan Hande Bio-Tech for cGMP violations related to data collection and security.

CDMO Vetter produces identifiable labeling for a top-ten pharmaceutical company.

IDT Biologika receives 2015 Facility of the Year Award or facility integration from ISPE.

Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.

Sonneborn announces that it named Gregg Kam as its new chief financial officer.

FlexiBulk tip packs save space and effort in the laboratory

With the inauguration of the Technology Center, the engineers, scientists, pharmacists, and IT developers for the first time closed the loop control circuit of a modular system along the entire process including production, sensor technology and controlling.

Endolysin technology targets unwanted bacteria, including resistant strains

Catalent completes a $52 million expansion program for advanced oral solid manufacturing solutions at its Winchester, KY, facility.

The acquisition expands Sartorius Stedim Biotech’s service portfolio.

Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies.

Recipharm makes a strategic investment in Synthonics and partners in development of novel compounds.

The single-use clarification system eliminates centrigues; harvesting can be performed in one step; and process robustness and predictability are ensured.

Japanese pharma market evolves towards generics and innovative products, reports CPhI, as CPhI Japan 2015 commences.

The license approval marks another milestone in Aptar Pharma’s ongoing service development to provide large-scale production services to customers.

Udit Batra, current head of Merck KGaA’s life science business, will lead the combined life science businesses following successful completion of Sigma-Aldrich acquisition.

Eppendorf announces that it won the Best New General Lab Product at the Scientists’ Choice Awards.

Meggle’s business group, Excipients and Technology, has appointed Alexander Torster, MBA, as its new head of sales and marketing.

Avomeen Analytical Services announces that David W. Riggs, PE will take the role of president of the company.

Theravectys has been granted authorization by the French National Agency for Medicines and Health Product Safety to produce lentiviral vectors for Phase I to Phase III testing at its manufacturing plant.

The move was made to meet an upsurge in Phase I/II GMP campaigns from clients in Europe and the United States.

The system is compatible with a wide range of industrial CHO cell lines.

Pall’s acquisition of BioSMB from Tarpon Biosystems expands its downstream continuous processing offerings.

Catalent acquires Pharmapak Technologies, a pharmaceutical packaging company based in New South Wales, Australia.

Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.